Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma.
Luo H, Zhang H, Mao J, Cao H, Tao Y, Zhao G, Zhang Z, Zhang N, Liu Z, Zhang J, Luo P, Xia Y, Cheng Y, Xie Z, Cheng Q, Liu G.
Luo H, et al. Among authors: cheng y, cheng q.
Cell Death Dis. 2023 Apr 3;14(4):235. doi: 10.1038/s41419-023-05753-9.
Cell Death Dis. 2023.
PMID: 37012233
Free PMC article.
Review.